Global Health Ltd Q2 FY26 Earnings Analysis
Published 5 Jul 2026 | Healthcare Services | Market Cap: ₹37.9K Cr
Price
₹1,425
Market Cap
₹37.9K Cr
P/E Ratio
66.2
How does Global Health Ltd rank in Healthcare Services?
Compare Global Health Ltd against every Healthcare Services company this quarter on revenue, margins and earnings-call signals.
Global Health Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹1.2K Cr, net profit ₹142 Cr.
Full financials →Earnings Summary
Developing hospitals (Lucknow, Patna, Noida) continue strong double-digit growth; revenue up ~30% YoY including Noida. Management is optimistic about future growth, expecting steady ramp-up and improved performance in developing hospitals like Noida, Lucknow, Patna, and Ranchi over the next 12-18 months.
📊 Revenue & Sales Performance
- →Developing hospitals (Lucknow, Patna, Noida) continue strong double-digit growth; revenue up ~30% YoY including Noida.
- →Lucknow hospital showing 30% inpatient volume growth, occupancy ~67%, driven by added clinical talent and specialties.
- →Ranchi facility expanding with new specialties and Oncology services planned; volumes growing ~15% YoY.
- →Noida hospital operational since Sept 2025, early contribution noted; insurance empanelments expected soon to accelerate growth.
- →Additional beds opened in Patna and Lucknow; more bed additions planned, supporting volume growth without necessarily requiring new hospitals.
- →New projects in Guwahati, Mumbai (Oshiwara), South Delhi, and Pitampura progressing; expected commissioning ~3-4 years out.
- →Growth drivers include bed expansion, specialist additions, and procedural complexity (e.g., robotic surgeries).
- →International patient revenue up 49% YoY, indicating growth potential from overseas market.
📈 Profitability & Margins
- →Management is optimistic about future growth, expecting steady ramp-up and improved performance in developing hospitals like Noida, Lucknow, Patna, and Ranchi over the next 12-18 months.
- →New facilities (e.g., Ranchi expansion with 110 beds, Lucknow additions) are expected to gradually improve EBITDA margins as they stabilize.
- →Mature hospitals showing modest EBITDA growth (~2% YoY); expects further margin improvement as additional manpower cost normalizes.
- →Noida operational losses (~INR 20 crore EBITDA loss currently) expected to reduce as the hospital scales up, but no specific timeline or numbers given.
- →ARPOB (average revenue per occupied bed) expected to stay strong with specialty mix optimization and growing complex care, especially in developing hospitals.
- →New projects (Mumbai, Guwahati, South Delhi, Pitampura) are 3-4 years away, anticipated to contribute to growth beyond FY27.
- →Conservative pricing approach maintained, with selective modest price increases; Patna price unchanged due to market strategy.
- →Overall outlook reflects confidence in sustained volume growth, margin improvement, and disciplined capital allocation.
🏗️ Capital Expenditure Plans
- →Guwahati Project: Completed acquisition of 3.5-acre land (~INR 600 million); Bhoomi Pujan done on October 31, 2025; construction commencement underway; expected 3-4 years to complete.
- →Mumbai, Oshiwara Project: Received approval for increased FSI, expanding bed capacity from 500 to 750; Board approved new project cost of INR 15,300 million including land, construction, medical equipment, and INR 850 million for staff residential apartments; construction to start soon.
- →South Delhi & Pitampura Projects: Digging started in South Delhi; Pitampura plans submitted for approval and construction to commence post-approval; timeline also expected around 3-4 years.
- →Ranchi Expansion: Commissioned 110 new beds; plans to add Oncology services and optimize specialty mix.
- →Noida Hospital: Operational since September 2025; ongoing ramp-up and investments expected.
- →Overall, multiple projects underway with 3-4 year build-out timelines and continued capital allocation focused on growth and strategic expansion.
💰 Fundraising & Capital Structure
- →There is no explicit mention of any current or future fundraising through debt or equity in the provided transcript.
- →The company highlights disciplined capital allocation and maintains a healthy balance sheet.
- →Expansion projects like Guwahati, Mumbai, South Delhi, Pitampura, and others are ongoing, with construction timelines around 3 to 4 years, but no specific mention of fundraising plans related to these.
- →The company seems focused on steady growth and operational ramp-up without indicating immediate need for additional funds via debt or equity.
- →No direct guidance or announcements regarding fundraising were made during the Q2 FY26 earnings call.
📋 Order Book & Pipeline
Key Metrics
Frequently Asked Questions
What were Global Health Ltd Q2 FY26 results?
Developing hospitals (Lucknow, Patna, Noida) continue strong double-digit growth; revenue up ~30% YoY including Noida. Management is optimistic about future growth, expecting steady ramp-up and improved performance in developing hospitals like Noida, Lucknow, Patna, and Ranchi over the next 12-18 months.
What is Global Health Ltd share price analysis?
Global Health Ltd currently shows a neutral. The stock trades at a P/E of 66.2 with a market cap of ₹37,919 Cr. Investors should review the full earnings analysis for detailed insights.
Is Global Health Ltd planning capital expenditure?
Guwahati Project: Completed acquisition of 3.5-acre land (~INR 600 million); Bhoomi Pujan done on October 31, 2025; construction commencement underway; expected 3-4 years to complete.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.